Skip to main content
ES
v1.2
Log in
M

Molbio Diagnosti

MOLBIO DIAGNOSTINSE
₹1,574.4+145.10 (+10.15%)as of 2026-10-16
Market Cap
₹18,087Cr.
P/E Ratio
83.3
P/B Ratio
—
EPS (TTM)
₹18.90
Day Range
₹1,424.7 – ₹1,673.7
Div Yield
0%
ROCE
18%
ROE
13.8%
52W Low: ₹1,01252W High: ₹1,687
Themes:🏥 Healthcare & Hospitals
Descriptive screens built from published data — not investment advice.

At a glance

  • Sales have grown 59.0% a year over three years.
  • Debt is 0.31× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Molbio_Diagnosti — Price
Interval
||
Style
Failed: 503

Scorecard

Market: risk-off · breadth 37
67RS Rankvs all stocks, 1–99
33 ▲Trend (ADX)trend strength
1/4CAN SLIMprice & volume checks
upSupertrendprice vs trailing line
accum.Volume Flowbuying vs selling volume

Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.

Evenstocks Score

Middle third
5.8/ 10Overall
3/ 10Valuation
7/ 10Quality
4/ 10Fundamental
9/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 83.3P/E: 83.3 | P/B: N/A
Growth
GrowingSales CAGR — 3Y: 59% · 1Y: 35%
Profitability
ModerateROCE: 18% | ROE: 13.8%

Key Metrics

Valuation
PEG Ratio 0.75
Price / Sales 13.78x
Margins & returns
Operating Margin 19%
Net Margin 11.0%
Return on Assets 8.3%

Frequently Asked Questions

MarketsPortfolioChart